Skip to main content
Year archive

Telix Pharmaceuticals Ltd — 2020 filings

All 101 regulatory filings released by Telix Pharmaceuticals Ltd (TLX) in 2020, sourced directly from the official regulator.

101 Filings
2020 Period
2020 filings (101)
Filing Released Lang
TLX101 Glioblastoma Therapy - Clinical Update 2 pages 212.5KB
Regulatory Filings
2020-12-22 English
Change in substantial holding 4 pages 699.2KB
Regulatory Filings
2020-12-16 English
Appendix 2A - issue of shares from exercise of options 15 pages 220.8KB
Regulatory Filings
2020-12-16 English
Cleansing Notice under section 708A Corporations Act 1
Regulatory Filings
2020-12-16 English
Urologic Oncology Alliance with Mauna Kea Technologies 2 pages 202.2KB
Regulatory Filings
2020-12-15 English
New Drug Submission filed with Health Canada for TLX591-CDx 2 pages 217.4KB
Regulatory Filings
2020-12-15 English
Telix and Kanazawa University Phase I trial of TLX591-CDx 2 pages 210.0KB
Regulatory Filings
2020-12-13 English
Telix Completes Acquisition of TheraPharm GmbH 1 pa
Regulatory Filings
2020-12-13 English
Appendix 2A - shares issued as consideration for acquisition 15 pages 230.4KB
Regulatory Filings
2020-12-13 English
Appendix 2A - issue of shares from exercise of options 15 pages 219.5KB
Regulatory Filings
2020-12-13 English
Cleansing Notice under section 708A Corporations Act 1
Regulatory Filings
2020-12-13 English
IP Agreement with U Southampton for access to TRALA data 2 pages 218.5KB
Regulatory Filings
2020-12-13 English
Release of shares from voluntary escrow 1 page 189.
Regulatory Filings
2020-12-09 English
FDA New Drug Application for TLX591-CDx Proceeds to Review 2 pages 220.6KB
Regulatory Filings
2020-12-08 English
TGA Priority Review Granted for Prostate Cancer Imaging 2 pages 210.4KB
Regulatory Filings
2020-12-06 English
Telix and DuChemBio - South Korea Partnership 2 pages 222.1KB
Regulatory Filings
2020-12-02 English
ProstACT Phase III Study Clinical Development Update 2 pages 213.0KB
Regulatory Filings
2020-12-02 English
Overview of ProstACT Phase III Study - Investor supplement 8 pages 9.3MB
Regulatory Filings
2020-12-02 English
FDA Approves 68Ga-PSMA Imaging for Use at UCLA and UCSF 1
Regulatory Filings
2020-12-01 English
Approval for Ph I study of next generation product TLX592 2 pages 209.7KB
Regulatory Filings
2020-12-01 English
Investor Briefing on First-in-Human Translation of TLX592 13 pages 2.2MB
Regulatory Filings
2020-12-01 English
Briefing for Investor call - TheraPharm GmbH Acquisition 17 pages 2.0MB
Regulatory Filings
2020-11-30 English
Telix Acquires TheraPharm GmbH 4 pages 250.3KB
Regulatory Filings
2020-11-29 English
Proposed issue of Securities - TLX 5 pages 27.8KB
Regulatory Filings
2020-11-29 English
Acquisition of TheraPharm GmbH - Investor Call 1 pa
Regulatory Filings
2020-11-29 English
Trading Halt 2 pages 287.0KB
Regulatory Filings
2020-11-26 English
Prostate Cancer Therapy FDA Meeting Update 1 page 2
Regulatory Filings
2020-11-24 English
NDA for Prostate Cancer Imaging accepted by US FDA 2 pages 219.5KB
Regulatory Filings
2020-11-23 English
TLX receives EUR545k Belgian Research Grant 2 pages 210.8KB
Regulatory Filings
2020-11-18 English
Becoming a substantial holder 36 pages 6.3MB
Regulatory Filings
2020-11-08 English
App 2A quotation for shares issued in strategic transaction 15 pages 228.2KB
Regulatory Filings
2020-11-05 English
Investor Briefing - Asia Strategy 15 pages 2.5MB
Regulatory Filings
2020-11-02 English
Appendix 2A - issue of shares on exercise of options 15 pages 219.1KB
Regulatory Filings
2020-11-02 English
Cleansing Notice - issue of shares from exercise of options 1
Regulatory Filings
2020-11-02 English
Appendix 3Y - change in Director interests - O Buck 2 pages 212.5KB
Regulatory Filings
2020-11-02 English
Strategic Licence and Partnership for Greater China Market 3 pages 241.9KB
Regulatory Filings
2020-11-01 English
Appendix 3B - Proposed Issue of Securities 52 pages 656.5KB
Regulatory Filings
2020-11-01 English
Investor Call - Strategic Licence and Commercial Partnership 1
Regulatory Filings
2020-11-01 English
App 4C and Activities Report for September 2020 Quarter 11 pages 1.4MB
Regulatory Filings
2020-10-29 English
Trading Halt 2 pages 286.8KB
Regulatory Filings
2020-10-29 English
Licence Agmt with DKFZ for Image-Guided Prostate Surgery 2 pages 218.5KB
Regulatory Filings
2020-10-27 English
Completion of PhI Enrolment of Japanese Renal Cancer Study 2 pages 205.1KB
Regulatory Filings
2020-10-26 English
Appendix 3G - issue of Rights under Equity Incentive Plan 13 pages 227.1KB
Regulatory Filings
2020-10-12 English
FDA grants Orphan Drug Designation for glioma imaging agent 2 pages 214.8KB
Regulatory Filings
2020-10-05 English
Telix submits NDA to US FDA for Prostate Cancer Imaging 2 pages 205.8KB
Regulatory Filings
2020-09-23 English
First patients dosed in Phase I study of APOMAB theranostic 2 pages 204.1KB
Regulatory Filings
2020-09-20 English
Strategic Collaboration with Varian for Prostate Imaging 2 pages 216.3KB
Regulatory Filings
2020-09-02 English
IRE Distribution Partnership for Prostate Cancer Imaging 2 pages 205.2KB
Regulatory Filings
2020-08-31 English
FDA grants orphan drug designation for TLX102 2 pages 202.5KB
Regulatory Filings
2020-08-30 English
Half Year Shareholder Update 34 pages 3.1MB
Regulatory Filings
2020-08-20 English
Report for half-year to 30 June 2020 29 pages 965.3KB
Regulatory Filings
2020-08-19 English
First patient dosed in renal cancer imaging study in Japan 2 pages 208.8KB
Regulatory Filings
2020-08-17 English
Investor call - H1 Results and Company Update 1 pag
Regulatory Filings
2020-08-10 English
Drug Master File for Glioblastoma Product Filed with FDA 2 pages 207.9KB
Regulatory Filings
2020-08-10 English
Appendix 4C and Activities Report - June 2020 quarter 10 pages 1.3MB
Regulatory Filings
2020-07-26 English
Receipt of $11.4M R&D tax rebate 1 page 207.3KB
Regulatory Filings
2020-07-20 English
App 2A - issue of shares following exercise of options 15 pages 166.5KB
Regulatory Filings
2020-07-14 English
FDA feedback on Prostate Cancer Therapy Phase 3 Trial Design 2 pages 190.8KB
Regulatory Filings
2020-07-07 English
Strategic collaboration with RefleXion for high-risk cancers 2 pages 190.5KB
Regulatory Filings
2020-07-07 English
App 3G - issue and lapse of unlisted share options 13 pages 353.9KB
Regulatory Filings
2020-07-01 English
FDA grants breakthrough designation for TLX250-CDx product 1
Regulatory Filings
2020-06-30 English
Recommencement of ZIRCON Phase III Trial Recruitment in EU 1
Regulatory Filings
2020-06-17 English
Update on New Drug Application for Prostate Cancer Imaging 1
Regulatory Filings
2020-06-09 English
Presentation to Jefferies Virtual Healthcare Conference 21 pages 14.4MB
Regulatory Filings
2020-06-03 English
Appointment of Dr Colin Hayward as Chief Medical Officer 2 pages 191.3KB
Regulatory Filings
2020-06-01 English
Appendix 2A - shares issued on exercise of options 15 pages 229.8KB
Regulatory Filings
2020-05-31 English
Appendix 2A - issues of shares on exercise of options 15 pages 166.5KB
Regulatory Filings
2020-05-14 English
Telix and Pharmalogic US Distribution Agreement 2 pages 223.1KB
Regulatory Filings
2020-05-14 English
July Pre-IND Meeting with US FDA for Ph III ProstACT Study 1
Regulatory Filings
2020-05-13 English
Chairman's Address to Annual General Meeting 2 pages 191.4KB
Regulatory Filings
2020-05-11 English
CEO's Address to Annual General Meeting 14 pages 6.1MB
Regulatory Filings
2020-05-11 English
AGM - Results of Meeting 2 pages 290.0KB
Regulatory Filings
2020-05-11 English
Appendix 3G - issue of unlisted Share Options following AGM 13 pages 450.9KB
Regulatory Filings
2020-05-11 English
App 3Y Change in Director Interests - C Behrenbruch 3 pages 218.5KB
Regulatory Filings
2020-05-11 English
Submission of European Marketing Authorisation Application 2 pages 210.9KB
Regulatory Filings
2020-04-30 English
Seneffe Manufacturing Facility - Shareholder Walkthrough 12 pages 12.8MB
Regulatory Filings
2020-04-27 English
Cover note to Seneffe Facility - Shareholder Walkthrough 1
Regulatory Filings
2020-04-27 English
Telix enters exclusive licence with Osaka University 2 pages 193.7KB
Regulatory Filings
2020-04-26 English
Quarterly Shareholder Update 12 pages 1.0MB
Regulatory Filings
2020-04-21 English
Investor conference call - transcript of CEO presentation 8 pages 210.4KB
Regulatory Filings
2020-04-21 English
Appendix 4C and Activity Report March 2020 quarter 8 pages 516.3KB
Regulatory Filings
2020-04-20 English
AGM Notice of Meeting 29 pages 397.4KB
Regulatory Filings
2020-04-08 English
Commercial Distribution Agmt for Prostate Cancer Diagnostic 2 pages 189.4KB
Regulatory Filings
2020-04-07 English
Telix completes acquisition of licensed production facility 2 pages 188.1KB
Regulatory Filings
2020-04-02 English
Telix and partners receive 500k CRC research grant 3 pages 193.2KB
Regulatory Filings
2020-03-15 English
Business Update - COVID-19 2 pages 191.9KB
Regulatory Filings
2020-03-12 English
Prof. Frederik Giesel joins Scientific Advisory Board 2 pages 191.8KB
Regulatory Filings
2020-03-08 English
Appendix 3Y - Change in Director Interests - M Nelson 3 pages 102.1KB
Regulatory Filings
2020-03-03 English
Positive FDA feedback on NDA submission process 2 pages 183.3KB
Regulatory Filings
2020-02-24 English
Appendix 4G - Key to Governance Disclosures 11 pages 187.3KB
Regulatory Filings
2020-02-23 English
Corporate Governance Statement for year ended 31 Dec 19 9 pages 274.2KB
Regulatory Filings
2020-02-23 English
Appendix 4E - Summary of Results 1 page 137.4KB
Regulatory Filings
2020-02-23 English
Annual Report for year ended 31 December 2019 96 pages 6.2MB
Regulatory Filings
2020-02-23 English
European Leadership Changes and Appointment VP Sales 2 pages 185.1KB
Regulatory Filings
2020-02-20 English
Appendix 3G - exercise of unlisted share options 12 pages 165.5KB
Regulatory Filings
2020-02-12 English
Appendix 3Y - O Buck - exercise of share options 3 pages 100.2KB
Regulatory Filings
2020-02-12 English
App 2A - Quotation of shares issued on exercise of options 17 pages 353.5KB
Regulatory Filings
2020-02-12 English
Appendix 4C - December 2019 Quarter 5 pages 1.0MB
Regulatory Filings
2020-01-28 English
Sales Note to accompany December 2019 quarter Appendix 4C 2 pages 196.1KB
Regulatory Filings
2020-01-28 English
Telix Granted FDA Approval for ZIRCON Renal Cancer Imaging 1
Regulatory Filings
2020-01-22 English
Appendix 3G - issue of unlisted share options 14 pages 369.5KB
Regulatory Filings
2020-01-15 English